NEW YORK (AP) — In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion.
Mylan offers about $29B for rival generic drugmaker Perrigo
source U.S. News - News http://ift.tt/1Fn0fql
Mylan offers about $29B for rival generic drugmaker Perrigo
source U.S. News - News http://ift.tt/1Fn0fql
No comments:
Post a Comment